Delivery Order SPE2DX22D0010-SPE2D826FAC58
- Not listed
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $272,697.60 to AmerisourceBergen Drug Corp on September 9, 2025, with completion targeted for September 10, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $875,168.94 to AmerisourceBergen Drug Corp on July 19, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the major pharmaceutical distributor for medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $358,839.04 to AmerisourceBergen Drug Corp on October 4, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,279.88 to AmerisourceBergen Drug Corp on August 25, 2025, with completion targeted for August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare procurement needs. The work will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $767,219.16 to AmerisourceBergen Drug Corp on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $151,201.44 to AmerisourceBergen Drug Corp on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies required by federal healthcare systems. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $39,468.80 to AmerisourceBergen Drug Corp on October 2, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,251.31 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply products. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor and is performing work at its...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $151,194.80 to AmerisourceBergen Drug Corp on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location and deliver...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $31,094.70 to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, which received no set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAC58Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $371,599.18 to AmerisourceBergen Drug Corp on October 4, 2025, with an ultimate completion date of October 6, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. As a major pharmaceutical distributor serving federal medical procurement needs, the company supplies a comprehensive range of healthcare commodities including brand-name and generic medications, vaccines, medical devices, and specialized supplies across multiple therapeutic domains. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply military healthcare programs worldwide. The DLA Troop Support Medical is establishing the Pharmaceutical Prime Vendor Global Program Generation V contracts with plans for multiple awards across separate regions, allowing AmerisourceBergen Drug Corp to serve customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $371.6k | 10/4/25 |